NGL Fine-Chem
₹2,646.8
4
+₹35.8+1.37% Friday 09:59
Statistics
Day High
2,699
Day Low
2,555.05
52W High
2,823.9
52W Low
1,728.1
Volume
5,377
Avg. Volume
6,656
Mkt Cap
15.41B
P/E Ratio
37.27
Dividend Yield
0.07%
Dividend
1.75
Upcoming
16
AUG
Dividend Ex
30
AUG
Dividend Payment
16
AUG 25
Dividend Ex
30
AUG 25
Dividend Payment
16
AUG 26
Dividend Ex
30
AUG 26
Dividend Payment
Dividends
0.07%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
13MayExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NGLFINE.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Show more...
CEO
Mr. Rahul Jayant Nachane
Country
IN
ISIN
INE887E01022